$0.49
0.00%
Nasdaq, Aug 30, 01:39 am CET
ISIN
US03828A1016
Symbol
APLT

Applied Therapeutics, Inc. Stock price

$0.49
+0.05 11.32% 1M
-0.02 3.09% 6M
-0.36 42.46% YTD
-5.59 91.90% 1Y
-1.00 66.93% 3Y
-23.61 97.96% 5Y
-8.91 94.76% 10Y
-8.91 94.76% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
-0.02 3.64%
ISIN
US03828A1016
Symbol
APLT
Industry

Key metrics

Basic
Market capitalization
$71.0m
Enterprise Value
$40.5m
Net debt
positive
Cash
$30.4m
Shares outstanding
141.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
591.3 | 208.7
EV/Sales
337.8 | 119.2
EV/FCF
negative
P/B
4.1
Financial Health
Equity Ratio
65.8%
Return on Equity
-185.3%
ROCE
-568.6%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$120.0k | $340.0k
EBITDA
$-110.8m | $-75.1m
EBIT
$-111.4m | $-97.7m
Net Income
$-67.7m | $-82.9m
Free Cash Flow
$-91.8m
Growth (TTM | estimate)
Revenue
-98.8% | -26.1%
EBITDA
- | 27.7%
EBIT
8.4% | 6.3%
Net Income
72.1% | 21.5%
Free Cash Flow
-25.3%
Margin (TTM | estimate)
Gross
-
EBITDA
-90,778.7% | -22,080.2%
EBIT
-91,301.6%
Net
-55,523.8% | -24,378.4%
Free Cash Flow
-75,226.2%
More
EPS
$-0.5
FCF per Share
$-0.6
Short interest
6.1%
Employees
35
Rev per Employee
$10.0k
Show more

Is Applied Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Applied Therapeutics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Applied Therapeutics, Inc. forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Applied Therapeutics, Inc. forecast:

Buy
64%
Hold
36%

Financial data from Applied Therapeutics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
0.12 0.12
99% 99%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 67 67
49% 49%
56,025%
- Research and Development Expense 44 44
49% 49%
36,900%
-111 -111
-
-92,292%
- Depreciation and Amortization 0.64 0.64
-
533%
EBIT (Operating Income) EBIT -111 -111
8% 8%
-92,823%
Net Profit -68 -68
72% 72%
-56,450%

In millions USD.

Don't miss a Thing! We will send you all news about Applied Therapeutics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Applied Therapeutics, Inc. Stock News

Neutral
GlobeNewsWire
19 days ago
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD
Neutral
GlobeNewsWire
3 months ago
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced key appointments to its executive leadership team with the promotions of Evan Bailey, MD, to Chief Medical Officer (CMO), effective June 15, 2025, and Dottie Caplan to Executive Vice President (EVP), ...
Neutral
GlobeNewsWire
4 months ago
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10MWRT and CMT-FOM Lower Limb domain at 12 months, though the primary endpoint of 10MWRT at 12 months was not statistically significant (the measure has since bee...
More Applied Therapeutics, Inc. News

Company Profile

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Head office United States
CEO Les Funtleyder
Employees 35
Founded 2016
Website www.appliedtherapeutics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today